GENERALI, DANIELE
 Distribuzione geografica
Continente #
AS - Asia 641
NA - Nord America 578
EU - Europa 552
SA - Sud America 49
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 1.841
Nazione #
US - Stati Uniti d'America 551
IT - Italia 194
CN - Cina 189
SG - Singapore 141
HK - Hong Kong 102
DE - Germania 79
VN - Vietnam 70
GB - Regno Unito 53
SE - Svezia 48
BR - Brasile 39
NL - Olanda 39
IN - India 34
RU - Federazione Russa 33
FR - Francia 31
BD - Bangladesh 23
FI - Finlandia 19
CA - Canada 16
JP - Giappone 15
PL - Polonia 15
TR - Turchia 15
ID - Indonesia 12
IE - Irlanda 10
KR - Corea 10
CI - Costa d'Avorio 7
EG - Egitto 6
TW - Taiwan 6
ES - Italia 5
PH - Filippine 5
CH - Svizzera 4
HU - Ungheria 4
MX - Messico 4
AR - Argentina 3
AT - Austria 3
IQ - Iraq 3
TH - Thailandia 3
AP - ???statistics.table.value.countryCode.AP??? 2
AU - Australia 2
BE - Belgio 2
CL - Cile 2
DK - Danimarca 2
GR - Grecia 2
JM - Giamaica 2
PT - Portogallo 2
RO - Romania 2
SV - El Salvador 2
UZ - Uzbekistan 2
VE - Venezuela 2
AL - Albania 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
CO - Colombia 1
CZ - Repubblica Ceca 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
SA - Arabia Saudita 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 1.841
Città #
Hong Kong 84
Dallas 83
Singapore 75
Ashburn 72
Frankfurt am Main 59
Milan 47
Beijing 46
Southend 44
San Jose 36
Los Angeles 33
Hanoi 26
Hefei 25
Chandler 22
Council Bluffs 21
Fairfield 21
Houston 18
Woodbridge 15
Ho Chi Minh City 13
New York 13
Bengaluru 11
Dublin 10
Helsinki 10
Moscow 10
Munich 10
Princeton 10
Seattle 10
Shanghai 10
Cambridge 9
Amsterdam 8
Lauterbourg 8
Naples 8
Rome 8
Seoul 8
Shenyang 8
Wilmington 8
Abidjan 7
Buffalo 7
Genoa 7
Redwood City 7
Santa Clara 7
Ann Arbor 6
Hangzhou 6
Istanbul 6
Jakarta 6
Tokyo 6
Turku 6
Bologna 5
Da Nang 5
Iwasakichō 5
Taipei 5
Chicago 4
Des Moines 4
Elk Grove Village 4
Guangzhou 4
Haiphong 4
Jacksonville 4
Modena 4
Mumbai 4
New Delhi 4
Paris 4
Poznan 4
The Hague 4
Warsaw 4
Wroclaw 4
Atlanta 3
Bangkok 3
Berlin 3
Boardman 3
Cangzhou 3
Dearborn 3
Jinan 3
Merate 3
Mexico City 3
Montreal 3
Nantes 3
Napoli 3
Nuremberg 3
Orem 3
Phoenix 3
The Dalles 3
Toronto 3
Trieste 3
Turin 3
Örebro 3
Aci Catena 2
Ankara 2
Baghdad 2
Bergamo 2
Bialystok 2
Biên Hòa 2
Brescia 2
Brugherio 2
Brussels 2
Can Tho 2
Caracas 2
Central District 2
Changsha 2
Chennai 2
Châteaurenard 2
Columbus 2
Totale 1.138
Nome #
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) 514
Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltration 261
International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the fourth symposium on primary systemic therapy in the management of operable breast cancer, Cremona, Italy (2010) 165
The role of bevacizumab in solid tumours : a literature based meta-analysis of randomised trials 163
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors 160
Oncoplastic and reconstructive surgery in SENONETWORK Italian breast centers: lights and shadows 157
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project 132
Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors : a meta-regression of randomised prospective studies 123
Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer 106
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2 63
A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials 55
Locally advanced breast cancers: the EUSOMA experience 20
Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis 6
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus report 6
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2 1
Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study 1
Totale 1.933
Categoria #
all - tutte 3.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.976


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 0 11 27
2021/2022193 28 26 19 16 13 14 9 12 17 15 7 17
2022/2023117 17 10 9 6 15 23 2 7 19 1 5 3
2023/2024106 1 6 5 2 18 2 11 14 5 7 18 17
2024/2025322 11 20 12 26 13 14 11 26 31 41 45 72
2025/2026986 77 72 135 58 50 40 181 33 103 118 119 0
Totale 1.933